A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works

Drug repurposing: progress, challenges and recommendations

Pushpakom, S., Iorio, F., Eyers, P. A., Escott, K. J., Hopper, S., Wells, A., Doig, A., Guilliams, T., Latimer, J., McNamee, C., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.168 · Cited by 4,718 · see citing works

Drug repositioning: identifying and developing new uses for existing drugs

Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237 · see citing works

A comprehensive map of molecular drug targets

Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T. I., et al. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.230 · Cited by 2,427 · see citing works

Alzheimer's disease

Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61349-9 · Cited by 2,336 · see citing works

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

Karran, E., Mercken, M., & Strooper, B. D. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3505 · Cited by 2,188 · cited 1× · see citing works

The Genome Sequence of the SARS-Associated Coronavirus

Marra, M. A., Jones, S. J. M., Astell, C. R., Holt, R. A., Brooks-Wilson, A. R., Butterfield, Y. S. N., Khattra, J. S., Asano, J. K., Barber, S., Chan, S. Y., et al. (2003) · Science · doi:10.1126/science.1085953 · Cited by 2,017 · see citing works

Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models

Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821 · see citing works

Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition

Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,692 · see citing works

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

Rothwell, P. M., Fowkes, F. G. R., Belch, J. F., Ogawa, H., Warlow, C. P., & Meade, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62110-1 · Cited by 1,497 · see citing works

Effects of chloroquine on viral infections: an old drug against today's diseases

Savarino, A., Boelaert, J. R., Cassone, A., Majori, G., & Cauda, R. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00806-5 · Cited by 1,272 · see citing works

Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements

Aggarwal, V., Tuli, H. S., Varol, A., Thakral, F., Yerer, M. B., Sak, K., Varol, M., Jain, A., Khan, M. A., & Sethi, G. (2019) · Biomolecules · doi:10.3390/biom9110735 · Cited by 1,235 · see citing works

Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance

Castellano, J. M., Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002156 · Cited by 1,227 · see citing works

Severe acute respiratory syndrome

Peiris, M. J. S., Guan, Y., & Yuen, K. (2004) · Nature Medicine · doi:10.1038/nm1143 · Cited by 1,135 · see citing works

Diet-Independent Correlations between Bacteria and Dysfunction of Gut, Adipose Tissue, and Liver: A Comprehensive Microbiota Analysis in Feces and Mucosa of the Ileum and Colon in Obese Mice with NAFLD

Gart, E., Lima, E. S., Schuren, F. H. J., de Ruiter, C., Attema, J., Verschuren, L., Keijer, J., Salic, K., Morrison, M. C., & Kleemann, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010001 · Cited by 1,098 · see citing works

Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities

Tabas, I., & Glass, C. K. (2013) · Science · doi:10.1126/science.1230720 · Cited by 1,093 · see citing works

ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models

Cramer, P. E., Cirrito, J. R., Wesson, D. W., Lee, C. Y. D., Karlo, J. C., Zinn, A. E., Casali, B. T., Restivo, J. L., Goebel, W. D., James, M. J., et al. (2012) · Science · doi:10.1126/science.1217697 · Cited by 1,050 · see citing works

Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria

Achan, J., Talisuna, A. O., Erhart, A., Yeka, A., Tibenderana, J., Baliraine, F. N., Rosenthal, P. J., & D’Alessandro, U. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-144 · Cited by 1,010 · see citing works

Antithyroid Drugs

Cooper, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra042972 · Cited by 1,008 · see citing works

Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors

Pillaiyar, T., Manickam, M., & Namasivayam, V. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2016.1256882 · Cited by 932 · see citing works

‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease

Chan, C. S., Guzmán, J. N., Ilijić, E., Mercer, J. N., Rick, C., Tkatch, T., Meredith, G. E., & Surmeier, D. J. (2007) · Nature · doi:10.1038/nature05865 · Cited by 905 · see citing works

Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner

Kalender, A., Selvaraj, A., Kim, S. Y., Gulati, P., Brûlé, S., Viollet, B., Kemp, B. E., Bardeesy, N., Dennis, P., Schlager, J. J., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.014 · Cited by 889 · see citing works

Crystal Structure of <i>Agaricus bisporus</i> Mushroom Tyrosinase: Identity of the Tetramer Subunits and Interaction with Tropolone

Ismaya, W. T., Rozeboom, H. J., Weijn, A., Mes, J. J., Fusetti, F., Wichers, H. J., & Dijkstra, B. W. (2011) · Biochemistry · doi:10.1021/bi200395t · Cited by 872 · see citing works

An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy

Pillaiyar, T., Manickam, M., Namasivayam, V., Hayashi, Y., & Jung, S. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01461 · Cited by 773 · see citing works

Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture

de Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J. H., & Snijder, E. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03011-14 · Cited by 727 · see citing works

Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer Disease&lt;subtitle&gt;A Randomized Controlled Trial&lt;/subtitle&gt;

Green, R. C. (2009) · JAMA · doi:10.1001/jama.2009.1866 · Cited by 643 · see citing works

Drug repurposing: a promising tool to accelerate the drug discovery process

Parvathaneni, V., Kulkarni, N. S., Muth, A., & Gupta, V. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.06.014 · Cited by 597 · cited 1× · see citing works

Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents

Miyamoto, S., Miyake, N., Jarskog, L. F., Fleischhacker, W. W., & Lieberman, J. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.47 · Cited by 576 · see citing works

Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis

Noto, H., Goto, A., Tsujimoto, T., & Noda, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033411 · Cited by 566 · see citing works

Acute myeloid leukaemia in adults

Ferrara, F., & Schiffer, C. A. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61727-9 · Cited by 566 · see citing works

World Alzheimer Report 2010: The global economic impact of dementia

Wimo, A. B., & Prince, M. J. (2010) · Cited by 559 · see citing works

Small molecules targeting severe acute respiratory syndrome human coronavirus

Wu, C., Jan, J., Ma, S.-H., Kuo, C., Juan, H., Cheng, Y. E., Hsu, H.-H., Huang, H., Wu, D., Brik, A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403596101 · Cited by 522 · see citing works

American Society of Health-System Pharmacists

Willett, K. C., & Morrill, A. M. (2016) · The SAGE Encyclopedia of Pharmacology and Society · doi:10.4135/9781483349985.n33 · Cited by 511 · see citing works

Regulation of the c-Abl and Bcr–Abl tyrosine kinases

Hantschel, O. D., & Superti‐Furga, G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1280 · Cited by 491 · see citing works

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis

Li, N.-C., Lee, A., Whitmer, R. A., Kivipelto, M., Lawler, E., Kazis, L. E., & Wolozin, B. (2010) · BMJ · doi:10.1136/bmj.b5465 · Cited by 486 · see citing works

Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes

Millan, M. J., Maiofiss, L., Cussac, D., Audinot, V., Boutin, J. A., & Newman‐Tancredi, A. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039867 · Cited by 485 · see citing works

Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals

Lee, M.-S., Hsu, C.-C., Wahlqvist, M. L., Tsai, H.-N., Chang, Y., & Huang, Y.-C. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-20 · Cited by 460 · see citing works

Quinoline hybrids and their antiplasmodial and antimalarial activities

Hu, Y., Gao, C., Zhang, S., Xu, L., Xu, Z. G., Feng, L., Wu, X., & Zhao, F. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.061 · Cited by 382 · see citing works

Clathrin-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus into Target Cells Expressing ACE2 with the Cytoplasmic Tail Deleted

Inoue, Y., Tanaka, N., Tanaka, Y., Inoue, S., Morita, K., Zhuang, M., Hattori, T., & Sugamura, K. (2007) · Journal of Virology · doi:10.1128/jvi.00253-07 · Cited by 369 · see citing works

Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis

Carballo‐Carbajal, I., Laguna, A., Romero‐Giménez, J., Cuadros, T., Bové, J., Martínez‐Vicente, M., Parent, A., González-Sepúlveda, M., Peñuelas, N., Torra, A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08858-y · Cited by 345 · see citing works

Cancer drug discovery by repurposing: teaching new tricks to old dogs

Gupta, S. C., Sung, B., Prasad, S., Webb, L. J., & Aggarwal, B. B. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.06.005 · Cited by 340 · see citing works

Valsartan lowers brain β-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease

Wang, J., Ho, L., Chen, L., Zhao, Z., Zhao, W., Qian, X., Humala, N., Seror, I., Bartholomew, S. R., Rosendorff, C., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31547 · Cited by 331 · see citing works

Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of α-synuclein in Parkinson's disease models.

Hebron, M., Lonskaya, I., & Moussa, C. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt192 · Cited by 319 · see citing works

Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-κB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation

Takada, Y., Bhardwaj, A., Potdar, P. D., & Aggarwal, B. B. (2004) · Oncogene · doi:10.1038/sj.onc.1208169 · Cited by 310 · see citing works

Inhibitors of Melanogenesis: An Updated Review

Pillaiyar, T., Namasivayam, V., Manickam, M., & Jung, S. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00967 · Cited by 309 · see citing works

A review of computational drug repurposing

Park, K. (2019) · Translational and Clinical Pharmacology · doi:10.12793/tcp.2019.27.2.59 · Cited by 303 · see citing works

Triazole derivatives and their antiplasmodial and antimalarial activities

Chu, X., Wang, C., Wang, W., Liang, L., Liu, W., Gong, K., & Sun, K. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.047 · Cited by 297 · see citing works

Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function

Ko, H. S., Lee, Y., Shin, J., Karuppagounder, S. S., Gadad, B. S., Koleske, A. J., Pletniková, O., Troncoso, J. C., Dawson, V. L., & Dawson, T. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006083107 · Cited by 286 · see citing works

Aspirin, salicylates, and cancer

Elwood, P. C., Gallagher, A. M., Duthie, G. G., Mur, L. A. J., & Morgan, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60243-9 · Cited by 280 · see citing works

Inhibitors of Alphavirus Entry and Replication Identified with a Stable Chikungunya Replicon Cell Line and Virus-Based Assays

Pohjala, L., Utt, A., Varjak, M., Lulla, A., Merits, A., Ahola, T., & Tammela, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028923 · Cited by 271 · see citing works

Nilotinib Effects in Parkinson’s disease and Dementia with Lewy bodies

Pagan, F., Hebron, M., Valadez, E. H., Torres-Yaghi, Y., Huang, X., Mills, R. R., Wilmarth, B. M., Howard, H., Dunn, C., Carlson, A., et al. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-160867 · Cited by 265 · see citing works

The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson’s disease

Karuppagounder, S. S., Brahmachari, S., Lee, Y., Dawson, V. L., Dawson, T. M., & Ko, H. S. (2014) · Scientific Reports · doi:10.1038/srep04874 · Cited by 264 · see citing works

Trends in development and approval times for new therapeutics in the United States

Reichert, J. M. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1178 · Cited by 261 · see citing works

The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease

Ilijić, E., Guzmán, J. N., & Surmeier, D. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.04.007 · Cited by 260 · see citing works

Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial

Low, J. G. H., Sung, C., Wijaya, L., Wei, Y., Rathore, A. P. S., Watanabe, S., Tan, B. H., Toh, L., Chua, L. T., Hou, Y., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70730-3 · Cited by 255 · see citing works

A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents

Madrid, P. B., Chopra, S., Manger, I. D., Gilfillan, L. G., Keepers, T. R., Shurtleff, A. C., Green, C. E., Iyer, L., Dilks, H. H., Davey, R. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060579 · Cited by 247 · see citing works

Nimodipine for primary degenerative, mixed and vascular dementia

Birks, J., & López-Arrieta, J. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000147 · Cited by 231 · see citing works

Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson’s disease

Imam, S. Z., Zhou, Q., Yamamoto, A., Valente, A. J., Ali, S. F., Bains, M., Roberts, J. L., Kahle, P. J., Clark, R. A., & Li, S. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1833-10.2011 · Cited by 214 · see citing works

Expression and 1,4-Dihydropyridine-Binding Properties of Brain L-Type Calcium Channel Isoforms

Sinnegger-Brauns, M. J., Huber, I. G., Koschak, A., Wild, C., Obermair, G. J., Einzinger, U., Hoda, J., Sartori, S. B., & Striessnig, J. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.049981 · Cited by 214 · see citing works

Current Status of Dengue Therapeutics Research and Development

Low, J. G. H., Ooi, E. E., & Vasudevan, S. G. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw423 · Cited by 211 · see citing works

Effects of Short-Course Oral Corticosteroid Therapy in Early Dengue Infection in Vietnamese Patients: A Randomized, Placebo-Controlled Trial

Tam, D. T. H., Ngoc, T. V., Tien, N. L. B., Kieu, N. T. T., Thuy, T. T. T., Thanh, L. T., Tam, C. T., Truong, N. T., Dung, N. T., Qui, P. T., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis655 · Cited by 210 · see citing works

Minocycline Reduces Microglial Activation and Improves Behavioral Deficits in a Transgenic Model of Cerebral Microvascular Amyloid

Fan, R., Xu, F., Previti, M. L., Davis, J., Grande, A. V., Robinson, J. K., & Nostrand, W. E. V. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4371-06.2007 · Cited by 195 · see citing works

2008 FDA drug approvals

Hughes, B. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2813 · Cited by 195 · see citing works

Targeting apoptosis pathways by Celecoxib in cancer

Jendrossek, V. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.01.012 · Cited by 194 · see citing works

Disruption of the retinoid signalling pathway causes a deposition of amyloid β in the adult rat brain

Corcoran, J. P. T., So, P. L., & Maden, M. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03563.x · Cited by 190 · see citing works

Evidence for defective retinoid transport and function in late onset Alzheimer's disease

Goodman, A. B., & Pardee, A. B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437937100 · Cited by 184 · see citing works

The unravelling of the complex pattern of tyrosinase inhibition

Deri, B., Kanteev, M., Goldfeder, M., Lecina, D., Guallar, V., Adir, N., & Fishman, A. (2016) · Scientific Reports · doi:10.1038/srep34993 · Cited by 183 · see citing works

Simvastatin Inhibits the Activation of p21rasand Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson's Disease

Ghosh, A., Roy, A., Matras, J., Brahmachari, S., Gendelman, H. E., & Pahan, K. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4144-09.2009 · Cited by 175 · see citing works

Cellular and molecular mechanisms controlling the migration of melanocytes and melanoma cells

Bonaventure, J., Domingues, M. J., & Larue, L. (2013) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12080 · Cited by 165 · see citing works

Angiotensin Receptor Blocker Prevented β-Amyloid-Induced Cognitive Impairment Associated With Recovery of Neurovascular Coupling

Takeda, S., Sato, N., Takeuchi, D., Kurinami, H., Shinohara, M., Niisato, K., Kano, M., Ogihara, T., Rakugi, H., & Morishita, R. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.138586 · Cited by 161 · see citing works

Protective Effects of Intranasal Losartan in the APP/PS1 Transgenic Mouse Model of Alzheimer Disease

Danielyan, L., Klein, R., Hanson, L. R., Buadze, M., Schwab, M. G., Gleiter, C. H., & Frey, W. H. (2010) · Rejuvenation Research · doi:10.1089/rej.2009.0944 · Cited by 158 · see citing works

L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease

Anekonda, T. S., Quinn, J. F., Harris, C., Frahler, K., Wadsworth, T. L., & Woltjer, R. L. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.020 · Cited by 155 · see citing works

Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial

Whitehorn, J., Châu, N. V. V., Khanh, L. P., Kien, D. T. H., Quyen, N. T. H., Tran, N. T. T., Hang, N. T., Truong, N. T., Tai, L. T. H., Huong, N. T. C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ949 · Cited by 154 · see citing works

Protective effects of ginsenoside Rg2 against glutamate-induced neurotoxicity in PC12 cells

Li, N., Liu, B., Dluzen, D. E., & Jin, Y. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.12.015 · Cited by 147 · see citing works

Liver-stage malaria parasites vulnerable to diverse chemical scaffolds

Derbyshire, E., Prudêncio, M., Mota, M., & Clardy, J. (2012) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1118370109 · Cited by 141 · see citing works

Tyrosinase-Expressing Neuronal Cell Line as in Vitro Model of Parkinson’s Disease

Hasegawa, T. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11031082 · Cited by 138 · see citing works

Melanins and Melanosomes

(2011) · Wiley eBooks · doi:10.1002/9783527636150 · Cited by 138 · see citing works

The amyloid cascade hypothesis

Korczyn, A. D. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.11.008 · Cited by 136 · see citing works

Telmisartan prevented cognitive decline partly due to PPAR-γ activation

Mogi, M., Li, J., Tsukuda, K., Iwanami, J., Min, L., Sakata, A., Fujita, T., Iwai, M., & Horiuchi, M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.032 · Cited by 134 · see citing works

The Potential Effect of Metformin on Cancer: An Umbrella Review

Yu, H., Zhong, X. Z., Gao, P., Shi, J., Wu, Z., Guo, Z., Wang, Z., & Song, Y. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00617 · Cited by 133 · see citing works

The Reaction of α-Synuclein with Tyrosinase

Tessari, I., Bisaglia, M., Valle, F., Samorı̀, B., Bergantino, E., Mammi, S., & Bubacco, L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709014200 · Cited by 132 · see citing works

The Nobel Chronicles

Raju, T. N. K. (2000) · The Lancet · doi:10.1016/s0140-6736(05)74775-9 · Cited by 128 · see citing works

How Thalidomide Works Against Cancer

Stewart, A. K. (2014) · Science · doi:10.1126/science.1249543 · Cited by 125 · see citing works

Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's disease

Greggio, E., Bergantino, E., Carter, D., Ahmad, R., Costin, G., Hearing, V. J., Clarimón, J., Singleton, A., Eerola, J., Hellström, O., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03019.x · Cited by 123 · see citing works

Simvastatin prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion and protein tyrosine nitration in mice

Selley, M. L. (2005) · Brain Research · doi:10.1016/j.brainres.2004.02.083 · Cited by 122 · see citing works

All-transretinoic acid as a novel therapeutic strategy for Alzheimer’s disease

Lee, H. P., Casadesús, G., Zhu, X., Lee, H., Perry, G. L., Smith, M. A., Gustaw‐Rothenberg, K., & Lerner, A. J. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.86 · Cited by 120 · see citing works

The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions

Polamreddy, P., & Gattu, N. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.022 · Cited by 119 · see citing works

Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent

Pantziarka, P., Sukhatme, V. V., Bouche, G., Melhuis, L., & Sukhatme, V. P. (2016) · ecancermedicalscience · doi:10.3332/ecancer.2016.610 · Cited by 118 · see citing works

Loperamide

Regnard, C., Twycross, R., Mihalyo, M., & Wilcock, A. (2011) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2011.06.001 · Cited by 117 · see citing works

Gemcitabine: A Critical Nucleoside for Cancer Therapy

Gesto, D., Cerqueira, N. M. F. S. A., Fernandes, P. A., & Ramos, M. J. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799320682 · Cited by 116 · see citing works

Selective Antihypertensive Dihydropyridines Lower Aβ Accumulation by Targeting both the Production and the Clearance of Aβ across the Blood-Brain Barrier

Paris, D., Bachmeier, C., Patel, N., Quadros, A., Volmar, C.-H., Laporte, V., Ganey, J., Beaulieu-Abdelahad, D., Ait-Ghezala, G., Crawford, F., et al. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00180 · Cited by 114 · see citing works

2014 FDA drug approvals

Mullard, A. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4545 · Cited by 113 · see citing works

Phase II safety, tolerability, and dose selection study of isradipine as a potential disease‐modifying intervention in early Parkinson's disease (STEADY‐PD)

Parkinson Study Group (2013) · Movement Disorders · doi:10.1002/mds.25639 · Cited by 112 · see citing works

Repurposing approved drugs on the pathway to novel therapies

Schein, C. H. (2019) · Medicinal Research Reviews · doi:10.1002/med.21627 · Cited by 110 · see citing works

Simvastatin Inhibits Activation of NADPH Oxidase/p38 MAPK Pathway and Enhances Expression of Antioxidant Protein in Parkinson Disease Models

Tong, H., Zhang, X., Meng, X., Lu, L., Mai, D., & Qu, S. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00165 · Cited by 109 · see citing works

Tetracycline repurposing in neurodegeneration: focus on Parkinson’s disease

Bortolanza, M., Nascimento, G. C., Socías, S. B., Ploper, D., Chehín, R. N., Raisman‐Vozari, R., & Bel, E. A. D. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1913-1 · Cited by 105 · see citing works

An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis

Lynch, P. M., Burke, C. A., Phillips, R. K. S., Morris, J. S., Slack, R. S., Wang, X., Liu, J., Patterson, S. L., Sinicrope, F. A., Rodrı́guez-Bigas, M. A., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307235 · Cited by 104 · see citing works

Simvastatin Potentiates TNF-α-Induced Apoptosis through the Down-Regulation of NF-κB-Dependent Antiapoptotic Gene Products: Role of IκBα Kinase and TGF-β-Activated Kinase-1

Ahn, K. S., Sethi, G., & Aggarwal, B. B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2507 · Cited by 104 · see citing works

Reductions in Amyloid-β-Derived Neuroinflammation, with Minocycline, Restore Cognition but do not Significantly Affect Tau Hyperphosphorylation

Parachikova, A. I., Vasilevko, V., Cribbs, D. H., LaFerla, F. M., & Green, K. N. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100204 · Cited by 101 · see citing works

Treating Alzheimer's disease by targeting iron

Nikseresht, S., Bush, A. I., & Ayton, S. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14567 · Cited by 98 · see citing works

Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms

Kumar, A., Sharma, N., Gupta, A. K., Kalonia, H., & Mishra, J. (2012) · Brain Research · doi:10.1016/j.brainres.2012.06.050 · Cited by 98 · see citing works

Prospects of Statins in Parkinson Disease

Roy, A., & Pahan, K. (2011) · The Neuroscientist · doi:10.1177/1073858410385006 · Cited by 96 · see citing works

Ibuprofen enhances the anticancer activity of cisplatin in lung cancer cells by inhibiting the heat shock protein 70

Endo, H., Yano, M., Okumura, Y., & Kido, H. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.550 · Cited by 95 · see citing works

Simulating Henipavirus Multicycle Replication in a Screening Assay Leads to Identification of a Promising Candidate for Therapy

Porotto, M., Orefice, G., Yokoyama, C. C., Mungall, B. A., Realubit, R. B., Sganga, M. L., Aljofan, M., Whitt, M. A., Glickman, J. F., & Moscona, A. (2009) · Journal of Virology · doi:10.1128/jvi.00164-09 · Cited by 94 · see citing works

Towards Retinoid Therapy for Alzheimers Disease

Shudo, K., Fukasawa, H., Nakagomi, M., & Yamagata, N. (2009) · Current Alzheimer Research · doi:10.2174/156720509788486581 · Cited by 91 · see citing works

Suppression of Aiolos and Ikaros expression by lenalidomide reduces human ILC3−ILC1/NK cell transdifferentiation

Mazzurana, L., Forkel, M., Rao, A., Acker, A. V., Kokkinou, E., Ichiya, T., Almer, S. H., Höög, C., Friberg, D., & Mjösberg, J. (2019) · European Journal of Immunology · doi:10.1002/eji.201848075 · Cited by 91 · see citing works

Naproxen Induces Cell-Cycle Arrest and Apoptosis in Human Urinary Bladder Cancer Cell Lines and Chemically Induced Cancers by Targeting PI3K

Kim, M.-S., Kim, J., Lim, D. Y., Huang, Z., Chen, H., Langfald, A., Lubet, R. A., Grubbs, C. J., Dong, Z., & Bode, A. M. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0288 · Cited by 89 · see citing works

Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro

Shin, J. S., Jung, E., Kim, M., Baric, R. S., & Go, Y. Y. (2018) · Viruses · doi:10.3390/v10060283 · Cited by 86 · see citing works

Doxycycline counteracts neuroinflammation restoring memory in Alzheimer's disease mouse models

Balducci, C., Santamaria, G., Vitola, P. L., Brandi, E., Grandi, F., Viscomi, A. R., Beeg, M., Gobbi, M., Salmona, M., Ottonello, S., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.002 · Cited by 81 · see citing works

Inhibitors of melanogenesis: a patent review (2009 – 2014)

Pillaiyar, T., Manickam, M., & Jung, S. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1039985 · Cited by 79 · see citing works

Single-agent lenalidomide induces complete remission of acute myeloid leukemia in patients with isolated trisomy 13

Fehniger, T. A., Byrd, J. C., Marcucci, G., Abboud, C. N., Kefauver, C. A., Payton, J. E., Vij, R., & Blum, W. G. (2008) · Blood · doi:10.1182/blood-2008-04-152678 · Cited by 76 · see citing works

Identification of Antihypertensive Drugs Which Inhibit Amyloid-β Protein Oligomerization

Zhao, W., Wang, J., Ho, L., Ono, K., Teplow, D. B., & Pasinetti, G. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0925 · Cited by 75 · see citing works

Molecular Mechanisms and Bioavailability of Polyphenols in Prostate Cancer

Costea, T., Nagy, P., Ganea, C., Szöllõsi, J., & Mocanu, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051062 · Cited by 74 · see citing works

Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice

García-Alloza, M., Prada, C. M., Lattarulo, C. R., Fine, S., Borrelli, L. A., Betensky, R., Greenberg, S. M., Frosch, M., & Bacskai, B. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06096.x · Cited by 73 · see citing works

Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson’s Disease: Rationale for Clinical Trial, and Current Progress

Carroll, C., & Wyse, R. K. H. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-171203 · Cited by 73 · see citing works

Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses

Kang, H., Kim, C., Kim, D., Song, J.-H., Choi, M., Choi, K., Kang, M.-G., Lee, K., Kim, H. S., Shin, J. S., et al. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.10.011 · Cited by 71 · see citing works

Degradation of tyrosinase induced by phenylthiourea occurs following Golgi maturation

Hall, A. M., & Orlow, S. J. (2005) · Pigment Cell Research · doi:10.1111/j.1600-0749.2005.00213.x · Cited by 71 · see citing works

Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease

Koronyo‐Hamaoui, M., Sheyn, J., Hayden, E. Y., Li, S., Fuchs, D.-T. S., Regis, G. C., Lopes, D. H. J., Black, K. L., Bernstein, K. E., Teplow, D. B., et al. (2019) · Brain · doi:10.1093/brain/awz364 · Cited by 70 · see citing works

Statin uses and mortality in colorectal cancer patients: An updated systematic review and meta‐analysis

Li, Y., He, X., Ding, Y., Chen, H., & Sun, L. (2019) · Cancer Medicine · doi:10.1002/cam4.2151 · Cited by 70 · see citing works

Evaluation of antileukaemic effects of rapamycin in patients with imatinib‐resistant chronic myeloid leukaemia

Sillaber, C., Mayerhofer, M., Böhm, A., Vales, A., Gruze, A., Aichberger, K. J., Esterbauer, H., Pfeilstöcker, M., Sperr, W. R., Pickl, W. F., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01892.x · Cited by 69 · see citing works

Novel tyrosinase inhibitory peptide with free radical scavenging ability

Shen, Z., Wang, Y., Guo, Z. G., Tan, T., & Zhang, Y. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2019.1661401 · Cited by 68 · see citing works

Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells

Soria-Castro, R., Schcolnik‐Cabrera, A., Rodríguez-López, G. M., Campillo-Navarro, M., Puebla‐Osorio, N., Estrada-Parra, S. A., Estrada‐García, I., Chacón‐Salinas, R., & Chávez-Blanco, A. D. (2019) · Journal of Immunology Research · doi:10.1155/2019/9678098 · Cited by 68 · see citing works

Minocycline as a potential therapeutic agent in neurodegenerative disorders characterized by protein misfolding

Noble, W. J., Garwood, C. J., & Hanger, D. P. (2009) · Prion · doi:10.4161/pri.3.2.8820 · Cited by 67 · see citing works

Retinoic acid normalizes nuclear receptor mediated hypo-expression of proteins involved in β-amyloid deposits in the cerebral cortex of vitamin A deprived rats

Husson, M., Enderlin, V., Delacourte, A., Ghenimi, N., Alfos, S., Pallet, V., & Higueret, P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.008 · Cited by 67 · see citing works

The Renin-Angiotensin System and Antihypertensive Drugs in Alzheimer's Disease: Current Standing of the Angiotensin Hypothesis?

Kehoe, P. G., & Passmore, P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111376 · Cited by 67 · see citing works

Towards the first targeted therapy for triple-negative breast cancer: Repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor

Ahmed, K., Koval, A., Xu, J., Bodmer, A., & Katanaev, V. L. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.02.018 · Cited by 67 · see citing works

Combination of Atorvastatin with Sulindac or Naproxen Profoundly Inhibits Colonic Adenocarcinomas by Suppressing the p65/β-Catenin/Cyclin D1 Signaling Pathway in Rats

Suh, N., Reddy, B. S., DeCastro, A., Paul, S., Lee, H. J., Smolarek, A. K., So, J. Y., Simi, B., Wang, C. X., Janakiram, N. B., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0222 · Cited by 66 · see citing works

Inhibitory effect of ibuprofen on tumor survival and angiogenesis in gastric cancer cell

Akrami, H., Aminzadeh, S., & Fallahi, H. (2014) · Tumor Biology · doi:10.1007/s13277-014-2952-3 · Cited by 66 · see citing works

Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature

Murteira, S., Ghezaiel, Z., Karray, S., & Lamure, M. P. (2013) · Journal of Market Access & Health Policy · doi:10.3402/jmahp.v1i0.21131 · Cited by 65 · see citing works

Tolerability of isradipine in early Parkinson's disease: A pilot dose escalation study

Simuni, T., Borushko, E., Avram, M. J., Miskevics, S. A., Martel, A., Zadikoff, C., Videnović, A., Weaver, F. M., Williams, K., & Surmeier, D. J. (2010) · Movement Disorders · doi:10.1002/mds.23308 · Cited by 65 · see citing works

Drug repurposing approaches to fight Dengue virus infection and related diseases

Radi, M. (2017) · Frontiers in bioscience · doi:10.2741/4630 · Cited by 64 · see citing works

Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs

Barratt, M. J., & Frail, D. E. (2012) · Cited by 64 · see citing works

Increases in β-amyloid protein in the hippocampus caused by diabetic metabolic disorder are blocked by minocycline through inhibition of NF-κB pathway activation

Cai, Z., Zhao, Y., Yao, S., & Zhao, B. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70504-7 · Cited by 62 · see citing works

Structural requirement(s) of N-phenylthioureas and benzaldehyde thiosemicarbazones as inhibitors of melanogenesis in melanoma B 16 cells

Pillaiyar, T., Hoang, T. A., LEE, K. ‐., Bang, S., Sharma, V. K., Yun, C., Roh, E., Hwang, B.-Y., Kim, Y. S., & Jung, S. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.02.067 · Cited by 62 · see citing works

Selective dihydropyiridine compounds facilitate the clearance of β-amyloid across the blood–brain barrier

Bachmeier, C. J., Beaulieu‐Abdelahad, D., MULLAN, M. J., & Paris, D. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.03.048 · Cited by 61 · see citing works

Repurposing sex steroids and related drugs as potential treatment for Parkinson's disease

Bourque, M., Morissette, M., & Paolo, T. D. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.04.005 · Cited by 61 · see citing works

The exploration of novel Alzheimer’s therapeutic agents from the pool of FDA approved medicines using drug repositioning, enzyme inhibition and kinetic mechanism approaches

Hassan, M., Raza, H., Abbasi, M. A., Moustafa, A. A., & Seo, S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.115 · Cited by 61 · see citing works

Non-Steroidal Anti-inflammatory Drugs Decrease E2F1 Expression and Inhibit Cell Growth in Ovarian Cancer Cells

Valle, B. L., D’Souza, T., Becker, K. G., Wood, W. H., Zhang, Y., Wersto, R. P., & Morin, P. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061836 · Cited by 61 · see citing works

The role of the South Pacific in modulating Tropical Pacific variability

Chung, C. T. Y., Power, S. B., Sullivan, A., & Delage, F. P. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-52805-2 · Cited by 57 · see citing works

Confounding of the association between statins and Parkinson disease: systematic review and meta‐analysis

Bykov, K., Yoshida, K., Weisskopf, M. G., & Gagne, J. J. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4079 · Cited by 55 · see citing works

Mouse Hepatitis Virus Type 2 Enters Cells through a Clathrin-Mediated Endocytic Pathway Independent of Eps15

Pu, Y., & Zhang, X. (2008) · Journal of Virology · doi:10.1128/jvi.00837-08 · Cited by 53 · see citing works

Interactions between retinoic acid, nerve growth factor and sonic hedgehog signalling pathways in neurite outgrowth

So, P.-L., Yip, P. K., Bunting, S. C. J., Wong, L., Mazarakis, N. D., Hall, S., McMahon, S. B., Maden, M., & Corcoran, J. P. T. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.06.027 · Cited by 51 · see citing works

A novel tyrosine kinase inhibitor AMN107 (nilotinib) normalizes striatal motor behaviors in a mouse model of Parkinson’s disease

Tanabe, A., Yamamura, Y., Kasahara, J., Morigaki, R., Kaji, R., & Goto, S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00050 · Cited by 50 · see citing works

Therapeutic Value of Voltage-Gated Sodium Channel Inhibitors in Breast, Colorectal, and Prostate Cancer: A Systematic Review

Martin, F., Ufodiama, C. E., Watt, I., Bland, M., & Brackenbury, W. J. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00273 · Cited by 47 · see citing works

Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]-N-[(piperidin-4-yl)methyl]methanamine (MMV019918) and analogues

Vallone, A., D’Alessandro, S., Brogi, S., Brindisi, M., Chemi, G., Alfano, G., Lamponi, S., Lee, S. G., Jez, J. M., Koolen, K. M. J., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.03.024 · Cited by 47 · see citing works

Repositioning of Thiourea-Containing Drugs as Tyrosinase Inhibitors

Choi, J., & Jee, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226114 · Cited by 46 · see citing works

The effect of topical diclofenac 3% and calcitriol 3 μg/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): A phase II, randomized controlled trial

Brinkhuizen, T., Frencken, K. J. A., Nelemans, P. J., Hoff, M. L. S., Kelleners-Smeets, N. W. J., Hausen, A. Z., van der Horst, M. P. J., Rennspiess, D., Winnepenninckx, V. J. L., Steensel, M. A. M. V., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.01.050 · Cited by 45 · see citing works

A translational continuum of model systems for evaluating treatment strategies in Alzheimer’s disease: isradipine as a candidate drug

Copenhaver, P. F., Anekonda, T. S., Musashe, D. T., Robinson, K. M., Ramaker, J. M., Swanson, T. L., Wadsworth, T. L., Kretzschmar, D., Woltjer, R. L., & Quinn, J. F. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.006841 · Cited by 44 · see citing works

Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients?

Elwood, P. C., Pickering, J. E., Morgan, G., Galante, J., Weightman, A. L., Morris, D., Longley, M. J., Mason, M. D., Adams, R., Dolwani, S., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203957 · Cited by 43 · see citing works

Diclofenac-Induced Apoptosis in the Neuroblastoma Cell Line SH-SY5Y: Possible Involvement of the Mitochondrial Superoxide Dismutase

Cecere, F., Iuliano, A., Albano, F., Zappelli, C., Castellano, I., Grimaldi, P., Masullo, M., Vendittis, E. D., & Ruocco, M. R. (2010) · BioMed Research International · doi:10.1155/2010/801726 · Cited by 42 · see citing works

Regulation by retinoic acid of insulin-degrading enzyme and of a related endoprotease in human neuroblastoma cell lines.

Melino, G., Draoui, M., Bernardini, S., Bellincampi, L., Reichert, U., & Cohen, P. (1996) · PubMed · Cited by 41 · see citing works

Clinical activity of mammalian target of rapamycin inhibitors in solid tumors

Alvarado, Y., Mita, M. M., Vemulapalli, S., Mahalingam, D., & Mita, A. C. (2011) · Targeted Oncology · doi:10.1007/s11523-011-0178-5 · Cited by 41 · see citing works

Simvastatin prevents neuroinflammation by inhibiting N‐methyl‐D‐aspartic acid receptor 1 in 6‐hydroxydopamine‐treated PC12 cells

Yan, J., Sun, J., Huang, L., Fu, Q., & Du, G. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23329 · Cited by 41 · see citing works

New leads for drug repurposing against malaria

Pazhayam, N. M., Chhibber‐Goel, J., & Sharma, A. K. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.08.006 · Cited by 41 · see citing works

Exploring the Interaction of N/S Compounds with a Dicopper Center: Tyrosinase Inhibition and Model Studies

Buitrago, E., Vuillamy, A., Boumendjel, A., Yi, W., Gellon, G., Hardré, R., Philouze, C., Serratrice, G., Jamet, H., Réglier, M., et al. (2014) · Inorganic Chemistry · doi:10.1021/ic501829s · Cited by 41 · see citing works

Design, synthesis and molecular simulation studies of dihydrostilbene derivatives as potent tyrosinase inhibitors

Vontzalidou, A., Zoidis, G., Chaita, E., Makropoulou, M., Aligiannis, N., Lambrinidis, G., Mikros, E., & Skaltsounis, A. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.07.029 · Cited by 40 · see citing works

Ibuprofen and hydrogel-released ibuprofen in the reduction of inflammation-induced migration in melanoma cells

Redpath, M., Marques, C. M. G., Dibden, C., Waddon, A. J., Lalla, R., & MacNeil, S. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09220.x · Cited by 40 · see citing works

Sequential RARβ and α signalling in vivo can induce adult forebrain neural progenitor cells to differentiate into neurons through Shh and FGF signalling pathways

Goncalves, M. B. C. V., Agudo‐Barriuso, M., Connor, S., McMahon, S. B., Minger, S. L., Maden, M., & Corcoran, J. P. T. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.11.018 · Cited by 39 · see citing works

Inhibition of Influenza Virus Replication by Targeting Broad Host Cell Pathways

Marois, I., Cloutier, A., Meunier, I., Weingartl, H. M., Cantin, A. M., & Richter, M. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110631 · Cited by 38 · see citing works

Structural requirement of phenylthiourea analogs for their inhibitory activity of melanogenesis and tyrosinase

Pillaiyar, T., LEE, K. ‐., Sharma, V. K., Joo, C., Cho, W., Roh, E., Kim, Y. S., & Jung, S. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.09.024 · Cited by 38 · see citing works

Analogues of ethionamide, a drug used for multidrug-resistant tuberculosis, exhibit potent inhibition of tyrosinase

Choi, J., Park, S., & Jee, J. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.10.033 · Cited by 38 · see citing works

A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine

Catalano, R., Rocca, R., Juli, G., Costa, G., Maruca, A., Artese, A., Caracciolo, D., Tagliaferri, P., Alcaro, S., Tassone, P., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111715 · Cited by 38 · see citing works

Favourable effects of nilvadipine on cognitive function and regional cerebral blood flow on SPECT in hypertensive patients with mild cognitive impairment

Hanyu, H., Hirao, K., Shimizu, S., Iwamoto, T., Koizumi, K., & Abe, K. (2007) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e32804c58aa · Cited by 37 · see citing works

Antiviral effects of quinine sulfate on HSV-1 HaCat cells infected: Analysis of the molecular mechanisms involved

Baroni, A., Paoletti, I., Ruocco, E., Ayala, F., Corrado, F., Wolf, R., Tufano, M. A., & Donnarumma, G. (2007) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2007.05.009 · Cited by 37 · see citing works

Nilotinib – Differentiating the Hope from the Hype

Wyse, R. K. H., Brundin, P., & Sherer, T. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-160904 · Cited by 36 · see citing works

Statin use is associated with a reduced incidence of colorectal cancer: a colonoscopy-controlled case–control study

Broughton, T., Sington, J., & Beales, I. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-36 · Cited by 36 · see citing works

Clathrin Mediates Infectious Hepatitis C Virus Particle Egress

Benedicto, I., Gondar, V., Molina‐Jiménez, F., Garcı́a-Buey, L., López‐Cabrera, M., Gastaminza, P., & Majano, P. L. (2015) · Journal of Virology · doi:10.1128/jvi.03620-14 · Cited by 36 · see citing works

Repurposing drugs to target the malaria parasite unfolding protein response

Chen, Y., Murillo-Solano, C., Kirkpatrick, M. G., Antoshchenko, T., Park, H., & Pizarro, J. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-28608-2 · Cited by 35 · see citing works

Diclofenac induced apoptosis via altering PI3K/Akt/MAPK signaling axis in HCT 116 more efficiently compared to SW480 colon cancer cells

Arısan, E. D., Ergül, Z., Bozdağ, G., Rencüzoğulları, Ö., Gürkan, A. Ç., Yerlikaya, P. O., Coşkun, D., & Palavan-Ünsal, N. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4378-2 · Cited by 35 · see citing works

Sodium valproate and 5-aza-2′-deoxycytidine differentially modulate DNA demethylation in G1 phase-arrested and proliferative HeLa cells

Rocha, M. A., Veronezi, G. M. B., Felisbino, M. B., Gatti, M. S. V., Tamashiro, W. M. D. S. C., & Mello, M. L. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-54848-x · Cited by 33 · see citing works

Drug repositioning for dengue haemorrhagic fever by integrating multiple omics analyses

Amemiya, T., Gromiha, M. M., Horimoto, K., & Fukui, K. (2019) · Scientific Reports · doi:10.1038/s41598-018-36636-1 · Cited by 33 · see citing works

Interaction of Ethambutol with Human Organic Cation Transporters of the SLC22 Family Indicates Potential for Drug-Drug Interactions during Antituberculosis Therapy

Pan, X., Wang, L., Gründemann, D., & Sweet, D. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01255-13 · Cited by 30 · see citing works

Inhibition of l-tyrosine-induced micronuclei production by phenylthiourea in human melanoma cells

Poma, A. M., Bianchini, S., & Miranda, M. (1999) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(99)00142-4 · Cited by 29 · see citing works

Repositioning Aspirin to Treat Lung and Breast Cancers and Overcome Acquired Resistance to Targeted Therapy

Li, L., Hu, M., Wang, T., Chen, H., & Xu, L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01503 · Cited by 28 · see citing works

Statin use and the risk of colorectal cancer in a population-based electronic health records study

Ibáñez‐Sanz, G., Guinó, E., Pontes, C., Quijada-Manuitt, M. Á., de la Peña, L., Aragón, M., Domínguez, M., Alonso, L. R., Blasco, A., García‐Rodríguez, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49877-5 · Cited by 27 · see citing works

The Prokinetic Cinitapride Has No Clinically Relevant Pharmacokinetic Interaction and Effect on QT during Coadministration with Ketoconazole

Robert, M., Salvà, M., Segarra, R. M., Pavesi, M., Esbrí, R., Roberts, D. J., & Golor, G. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.010835 · Cited by 26 · see citing works

Middle East Respiratory Syndrome-Coronavirus (MERS-CoV): An Updated Overview and Pharmacotherapeutics

Pillaiyar, T. (2015) · Medicinal Chemistry · doi:10.4172/2161-0444.1000287 · Cited by 26 · see citing works

Aligning the evidence with practice: NICE guidelines for drug treatment of Alzheimer’s disease

Ballard, C. G., Corbett, A., & Sharp, S. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.13 · Cited by 22 · see citing works

Repositioning of bromocriptine for treatment of acute myeloid leukemia

Lara-Castillo, M. C., Cornet-Masana, J. M., Etxabe, A., Banús‐Mulet, A., Torrente, M. Á., Nomdedéu, M., Díaz‐Beyá, M., Esteve, J., & Risueño, R. M. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1007-5 · Cited by 22 · see citing works

Thiopurine Drugs Repositioned as Tyrosinase Inhibitors

Choi, J., Lee, Y. M., & Jee, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010077 · Cited by 21 · see citing works

Pharmacovigilance and tuberculosis: applying the lessons of thioacetazone

Falzon, D., Hill, G. R., Pal, S. N., Suwankesawong, W., & Jaramillo, E. (2014) · Bulletin of the World Health Organization · doi:10.2471/blt.14.142570 · Cited by 20 · see citing works

Astemizole analogues with reduced hERG inhibition as potent antimalarial compounds

Tian, J., Vandermosten, L., Peigneur, S., Moreels, L., Rozenski, J., Tytgat, J., Herdewijn, P. A., den Steen, P. E. V., & Jonghe, S. D. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.10.004 · Cited by 20 · see citing works

Repositioning Salirasib as a new antimalarial agent

Porta, E. O. J., Verdaguer, I. B., Perez, C., Banchio, C., de Azevedo, M. F., Katzin, A. M., & Labadié, G. R. (2019) · MedChemComm · doi:10.1039/c9md00298g · Cited by 20 · see citing works

A combination of thalidomide and arsenic trioxide is effective and well tolerated in patients with myelodysplastic syndromes

Wei, W., Zhou, F., Zhang, Y., Guo, L., Shi, H., & Hou, J. (2012) · Leukemia Research · doi:10.1016/j.leukres.2011.12.023 · Cited by 19 · see citing works

The role of statins for primary prevention in non-elderly colorectal cancer patients.

Sehdev, A., Shih, Y. T., Huo, D., Vekhter, B. G., Lyttle, C. S., & Polite, B. N. (2014) · PubMed · Cited by 18 · see citing works

miR‑770‑5p modulates resistance to methotrexate in human colorectal adenocarcinoma cells by downregulating HIPK1

Zhang, D., Li, Y., & Sun, P. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8221 · Cited by 16 · see citing works

Recent Updates in Melanocyte Function: The Use of Promising Bioactive Compounds for the Treatment of Hypopigmentary Disorders

Ali, S., Naaz, I., Zaidi, K. U., & Ali, A. S. (2017) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666161223153953 · Cited by 16 · see citing works

Cinitapride Protects against Ethanol-lnduced Gastric Mucosal Injury in Rats: Role of 5-Hydroxytryptamine, Prostaglandins and Sulfhydryl Compounds

Romero, A. O. N.-D.-L.-L., pez, A. L. O., n, M. J. M. I., Casa, C. L., & Motilva, V. (2008) · Pharmacology · doi:10.1159/000139487 · Cited by 16 · see citing works

Update on the management of rosacea: a status report on the current role and new horizons with topical azelaic acid.

Rosso, J. Q. D., & Kircik, L. (2014) · PubMed · Cited by 14 · see citing works

Kinetics of tissue distribution and elimination of retinoid drugs in the rat. I. Acitretin.

Eisenhardt, E. U., & Bickel, M. H. (1994) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08301-1 · Cited by 14 · see citing works

The role of statins for primary prevention in non-elderly colorectal cancer patients.

Sehdev, A., Shih, Y. T., Vekhter, B. G., Lyttle, C. S., & Polite, B. N. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.1513 · Cited by 13 · see citing works

Screening a library of approved drugs reveals that prednisolone synergizes with pitavastatin to induce ovarian cancer cell death

Abdullah, M. I., Abed, M. N., Khanim, F. L., & Richardson, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-46102-1 · Cited by 12 · see citing works

A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia

Cahill, K. E., Karimi, Y. H., Karrison, T. G., Jain, N., Green, M., Weiner, H., Fulton, N. C., Kadri, S., Godley, L. A., Artz, A. S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000795 · Cited by 11 · see citing works

Thalidomide potentiates etoposide-induced apoptosis in murine neuroblastoma through suppression of NF-κB activation

Hiramatsu, T., Yoshizawa, J., Miyaguni, K., Sugihara, T., Harada, A., Kaji, S., Uchida, G., Kanamori, D., Baba, Y., Ashizuka, S., et al. (2018) · Pediatric Surgery International · doi:10.1007/s00383-018-4234-4 · Cited by 10 · see citing works

Cure of condyloma acuminata covering the glans penis using aminolevulinic acid/photodynamic therapy

Yin, G., Zhang, Y., Geng, M., Cai, B., & Zheng, Y. (2020) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2020.101658 · Cited by 9 · see citing works

Evaluation of Antiplasmodial Potential of C2 and C8 Modified Quinolines: in vitro and in silico Study

Kumar, R., Sharma, R., Kumar, I., Upadhyay, P., Dhiman, A. K., Kumar, R., Kumar, R., Purohit, R., Sahal, D., & Sharma, U. K. (2018) · Medicinal Chemistry · doi:10.2174/1573406414666181015144413 · Cited by 9 · see citing works

Melanogenesis-Inhibitory and Cytotoxic Activities of Triterpene Glycoside Constituents from the Bark of Albizia procera

Zhang, J., Akihisa, T., Kurita, M., Kikuchi, T., Zhu, W., Ye, F., Dong, Z., Liu, W., Feng, F., & Xu, J. (2018) · Journal of Natural Products · doi:10.1021/acs.jnatprod.8b00167 · Cited by 8 · see citing works

The Relapse rate in patients with actinic keratosis treated with diclofenac sodium 3% gel

Agata, J., Dini, V., Oranges, T., Colombo, G., Bruno, G., Sergio, D. M., & Romanelli, M. (2019) · International Journal Of Medical Science And Clinical Invention · doi:10.18535/ijmsci/v6i2.06 · Cited by 3 · see citing works

Drug repurposing for cancer therapy

Xia, Y., Sun, M., Huang, H., & Jin, W.-L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01808-1 · Cited by 443 · see citing works

Utilizing graph machine learning within drug discovery and development

Gaudelet, T., Day, B., Jamasb, A. R., Soman, J., Regep, C., Liu, G., Hayter, J. B. R., Vickers, R., Roberts, C., Tang, J., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab159 · Cited by 313 · see citing works

Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review

Hung, S. W., Zhang, R., Tan, Z., Chung, J. P. W., Zhang, T., & Wang, C. C. (2021) · Medicinal Research Reviews · doi:10.1002/med.21802 · Cited by 171 · see citing works

Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers

Begley, C. G., Ashton, M. R., Baell, J. B., Bettess, M. D., Brown, M. P., Carter, B. A., Charman, W. N., Davis, C., Fisher, S., Frazer, I. H., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd5524 · Cited by 158 · see citing works

Utilizing drug repurposing against COVID-19 – Efficacy, limitations, and challenges

Parvathaneni, V., & Gupta, V. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118275 · Cited by 138 · see citing works

Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: a pharmacoinformatics study

Sinha, S. K., Prasad, S. K., Islam, M. A., Gurav, S. S., Patil, R. B., AlFaris, N. A., Aldayel, T. S., AlKehayez, N. M., Wabaidur, S. M., & Shakya, A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1779132 · Cited by 131 · see citing works

Neuroimmune crosstalk in chronic neuroinflammation: microglial interactions and immune modulation

Müller, L., & Benedetto, S. D. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1575022 · Cited by 90 · see citing works

Repurposing drugs for the management of COVID-19

Cusinato, J., Cau, Y., Calvani, A. M., & Mori, M. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2021.1861248 · Cited by 79 · see citing works

Drug Repurposing in Cancer Therapy: Influence of Patient’s Genetic Background in Breast Cancer Treatment

Rodrigues, R. C., Duarte, D., & Vale, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084280 · Cited by 67 · see citing works

A comprehensive survey upon diverse and prolific applications of chitosan-based catalytic systems in one-pot multi-component synthesis of heterocyclic rings

Mousavi, H. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.06.123 · Cited by 65 · see citing works

A review on computer‐aided chemogenomics and drug repositioning for rational COVID ‐19 drug discovery

Maghsoudi, S., Shahraki, B. T., Rameh, F., Nazarabi, M., Fatahi, Y., Akhavan, O., Rabiee, M., Mostafavi, E., Lima, E. C., Saeb, M. R., et al. (2022) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14136 · Cited by 64 · see citing works

Glioblastoma multiforme: an updated overview of temozolomide resistance mechanisms and strategies to overcome resistance

Pu, J., Yuan, K., Tao, J., Qin, Y., Li, Y., Fu, J., Zhong, L., Zhou, H., Tang, Z., Li, L., et al. (2025) · Discover Oncology · doi:10.1007/s12672-025-02567-3 · Cited by 59 · see citing works

Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines

Awadasseid, A., Wu, Y., Tanaka, Y., & Zhang, W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111330 · Cited by 49 · see citing works

Looking at NSAIDs from a historical perspective and their current status in drug repurposing for cancer treatment and prevention

Ozleyen, A., Yılmaz, Y. B., Dönmez, S., Atalay, H. N., Antika, G., & Tumer, T. B. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04187-8 · Cited by 48 · see citing works

Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2

Wu, C., Hsiao, S.-H., & Wu, Y. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101011 · Cited by 47 · see citing works

DrugSpaceX: a large screenable and synthetically tractable database extending drug space

Yang, T., Li, Z. S., Chen, Y., Feng, D., Wang, G., Fu, Z., Ding, X., Tan, X., Zhao, J., Luo, X., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa920 · Cited by 49 · see citing works

The recent outbreaks of human coronaviruses: A medicinal chemistry perspective

Pillaiyar, T., Wendt, L. L., Manickam, M., & Easwaran, M. (2020) · Medicinal Research Reviews · doi:10.1002/med.21724 · Cited by 41 · see citing works

A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine

Catalano, R., Rocca, R., Juli, G., Costa, G., Maruca, A., Artese, A., Caracciolo, D., Tagliaferri, P., Alcaro, S., Tassone, P., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111715 · Cited by 38 · see citing works

Repurposing small-molecule drugs for modulating toxic protein aggregates in neurodegenerative diseases

Liu, W., Wang, G., Wang, Z., Wang, G., Huang, J., & Liu, B. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.04.003 · Cited by 38 · see citing works

Drug Repurposing of Quisinostat to Discover Novel Plasmodium falciparum HDAC1 Inhibitors with Enhanced Triple-Stage Antimalarial Activity and Improved Safety

Wang, M., Tang, T., Li, R., Huang, Z., Ling, D., Zheng, L., Ding, Y. P., Liu, T., Xu, W., Zhu, F., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01993 · Cited by 36 · see citing works

Neurokinin-1 Receptor (NK-1R) Antagonists as a New Strategy to Overcome Cancer Resistance

García‐Aranda, M., Téllez, T., McKenna, L., & Redondo, M. (2022) · Cancers · doi:10.3390/cancers14092255 · Cited by 36 · see citing works

Drug repositioning for cancer in the era of AI, big omics, and real-world data

Wieder, R., & Adam, N. R. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103730 · Cited by 31 · see citing works

Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2

Girgis, A. S., Panda, S. S., Kariuki, B. M., Bekheit, M. S., Barghash, R. F., & Aboshouk, D. R. (2023) · Molecules · doi:10.3390/molecules28186603 · Cited by 30 · see citing works

Drug Repurposing for the Management of Depression: Where Do We Stand Currently?

Sadeghi, H. M., Adeli, I., Mousavi, T., Daniali, M., Nikfar, S., & Abdollahi, M. R. (2021) · Life · doi:10.3390/life11080774 · Cited by 29 · see citing works

Mutant p53, the Mevalonate Pathway and the Tumor Microenvironment Regulate Tumor Response to Statin Therapy

Pereira, M., Matuszewska, K., Glogova, A., & Petrik, J. (2022) · Cancers · doi:10.3390/cancers14143500 · Cited by 28 · see citing works

Repositioning of Immunomodulators: A Ray of Hope for Alzheimer’s Disease?

Munafò, A., Burgaletto, C., Benedetto, G. D., Mauro, M. D., Mauro, R. D., Bernardini, R., & Cantarella, G. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.614643 · Cited by 27 · see citing works

PI3K/Akt/YAP signaling promotes migration and invasion of DLD‑1 colorectal cancer cells

Takeda, T., Yamamoto, Y., Tsubaki, M., Matsuda, T., Kimura, A., Shimo, N., & Nishida, S. (2022) · Oncology Letters · doi:10.3892/ol.2022.13226 · Cited by 27 · see citing works

Druggable targets from coronaviruses for designing new antiviral drugs

Silva, L. R., Santos-Júnior, P. F. D. S., Brandão, J. D. A., Anderson, L., Bassi, Ê. J., de Araújo‐Júnior, J. X., Cardoso, S. H., & da Silva‐Júnior, E. F. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115745 · Cited by 25 · see citing works

Application Progress of Organoids in Colorectal Cancer

Luo, L., Ma, Y., Zheng, Y., Su, J., & Huang, G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.815067 · Cited by 25 · see citing works

Ketamine can be produced by Pochonia chlamydosporia: an old molecule and a new anthelmintic?

Ferreira, S. R., Machado, A. R. T., Furtado, L. F. V., Gomes, J. H. D. S., de Almeida, R. M., Mendes, T. A. D. O., Maciel, V. N., Barbosa, F. S., de Carvalho, L. M., Bueno, L. L., et al. (2020) · Parasites & Vectors · doi:10.1186/s13071-020-04402-w · Cited by 23 · see citing works

Endometriosis: Molecular Pathophysiology and Recent Treatment Strategies—Comprehensive Literature Review

Sadłocha, M., Toczek, J., Major, K., Staniczek, J., & Stojko, R. (2024) · Pharmaceuticals · doi:10.3390/ph17070827 · Cited by 31 · see citing works

Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement.

Coban, M., Morrison, J. M., Maharjan, S., Hernandez Medina, D. H., Li, W., Zhang, Y. S., Freeman, W. D., Radisky, E. S., Roch, K. G. L., Weisend, C. M., et al. (2021) · eScholarship (California Digital Library) · Cited by 22 · see citing works

Development of Verapamil Hydrochloride-loaded Biopolymer-based Composite Electrospun Nanofibrous Mats: In vivo Evaluation of Enhanced Burn Wound Healing without Scar Formation

Barakat, H. S., Freag, M. S., Gaber, S. M., Oufy, A. A., & Abdallah, O. Y. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s389329 · Cited by 22 · see citing works

Drug Repositioning Using Computer-aided Drug Design (CADD)

Rawat, S., Subramaniam, K., Subramanian, S. K., Saravanan, S., Dhanabalan, S., Chidambaram, S. K. M., Stalin, B., Roy, A., Nagaprasad, N., Aruna, M., et al. (2023) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201024666230821103601 · Cited by 22 · see citing works

Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement

Coban, M., Morrison, J., Maharjan, S., Medina, D. H. H., Li, W.-L., Zhang, Y. S., Freeman, W., Radisky, E. S., Roch, K. L. L., Weisend, C. M., et al. (2020) · Biomolecules · doi:10.3390/biom11060787 · Cited by 24 · see citing works

Drug repurposing strategies and key challenges for COVID-19 management

Mule, S., Singh, A., Greish, K. F., Sahebkar, A., Kesharwani, P., & Shukla, R. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.2013852 · Cited by 22 · see citing works

Bestatin analogs-4-quinolinone hybrids as antileishmanial hits: Design, repurposing rational, synthesis, in vitro and in silico studies

Hassan, A. H. E., Mahmoud, K., Phan, T.-N., Shaldam, M. A., Lee, C. H., Kim, Y. J., Cho, S. B., Bayoumi, W. A., El‐Sayed, S. M., Choi, Y., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115211 · Cited by 21 · see citing works

Identification of LASSBio-1945 as an inhibitor of SARS-CoV-2 main protease (M PRO ) through in silico screening supported by molecular docking and a fragment-based pharmacophore model

Franco, L. S., Maia, R. D. C., & Barreiro, E. J. (2020) · RSC Medicinal Chemistry · doi:10.1039/d0md00282h · Cited by 21 · see citing works

An Overview on Taxol Production Technology and Its Applications as Anticancer Agent

Sharma, A., Bhatia, S. K., Banyal, A., Chanana, I., Kumar, A., Chand, D., Kulshrestha, S., & Kumar, P. (2022) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-022-0063-3 · Cited by 20 · see citing works

Simultaneous encapsulation of dasatinib and celecoxib into caseinate micelles towards improved in vivo anti-breast cancer efficacy with reduced drug toxicity

Lamey, C. A., Moussa, N., Helmy, M. W., Haroun, M., & Sabra, S. A. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104807 · Cited by 20 · see citing works

An overview of progress in human metapneumovirus (hMPV) research: Structure, function, and therapeutic opportunities

Krüger, N., Laufer, S., & Pillaiyar, T. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104364 · Cited by 20 · see citing works

Seleno-Analogs of Scaffolds Resembling Natural Products a Novel Warhead toward Dual Compounds

Astrain-Redín, N., Talavera, I., Moreno, E., Ramírez, M. J., Martínez‐Sáez, N., Encı́o, I., Sharma, A. K., Sanmartín, C., & Plano, D. (2023) · Antioxidants · doi:10.3390/antiox12010139 · Cited by 18 · see citing works

AI-driven drug discovery and repurposing using multi-omics for myocardial infarction and heart failure

Sabry, Z., Arora, H. S., Chandrasekaran, S., & Wang, Z. (2025) · Exploration of Medicine · doi:10.37349/emed.2025.1001340 · Cited by 17 · see citing works

Discovery of drug targets and therapeutic agents based on drug repositioning to treat lung adenocarcinoma

Graves, O. K., Kim, W., Özcan, M., Ashraf, S., Türkez, H., Yuan, M., Zhang, C., Mardinoğlu, A., & Li, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114486 · Cited by 17 · see citing works

Anti-breast cancer potential of a new xanthine derivative: In silico, antiproliferative, selectivity, VEGFR-2 inhibition, apoptosis induction and migration inhibition studies

Eissa, I. H., Yousef, R. G., Elkady, H., Elkaeed, E. B., Alsfouk, B. A. A., Husein, D. Z., Asmaey, M. A., Ibrahim, I. M., & Metwaly, A. M. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154894 · Cited by 17 · see citing works

Immune Checkpoint Inhibitors, Small-Molecule Immunotherapies and the Emerging Role of Neutrophil Extracellular Traps in Therapeutic Strategies for Head and Neck Cancer

O’Meara, C. H., Jafri, Z., & Khachigian, L. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411695 · Cited by 17 · see citing works

Genomic-Analysis-Oriented Drug Repurposing in the Search for Novel Antidepressants

Lesmana, M. H. S., Le, N. Q. K., Chiu, W., Chung, K., Wang, C., Irham, L. M., & Chung, M. (2022) · Biomedicines · doi:10.3390/biomedicines10081947 · Cited by 14 · see citing works

Recent Advances and Future Perspectives in Mitigating Invasive Antifungal-Resistant Pathogen Aspergillus fumigatus in Africa

Achilonu, C. C., Davies, A. A., Kanu, O. O., Noel, C. B., & Oladele, R. O. (2023) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-023-00269-4 · Cited by 14 · see citing works

Reprogramming cancer therapeutics through artificial intelligence-guided drug repurposing: Computational innovation, experimental validation, and translational challenges

Fawzy, M. P., Nafie, M. S., Nabih, N. W., Diab, M. K., Babker, A. M. A., Mohamed, H., Hassan, H. A. F. M., & Fahmy, S. A. (2026) · Artificial Intelligence in the Life Sciences · doi:10.1016/j.ailsci.2026.100168 · Cited by 15 · see citing works

Computational and biological approaches in repurposing ribavirin for lung cancer treatment: Unveiling antitumorigenic strategies

Paudel, K. R., Singh, M., Rubis, G. D., Kumbhar, P., Mehndiratta, S., Kokkinis, S., Sherkawi, T. E., Gupta, G., Singh, S. K., Malik, M. Z., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122859 · Cited by 12 · see citing works

Drug repositioning for Parkinson’s disease: An emphasis on artificial intelligence approaches

Karimi-Sani, I., Sharifi, M., Abolpour, N., Lotfi, M., Atapour, A., Takhshid, M. A., & Sahebkar, A. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102651 · Cited by 12 · see citing works

Functional diversification and exaptation: the emergence of new drug uses in the pharma industry

Andriani, P., & Cattani, G. (2022) · Industrial and Corporate Change · doi:10.1093/icc/dtac023 · Cited by 12 · see citing works

Utilising Graph Machine Learning within Drug Discovery and DevelopmentPreprint

Gaudelet, T., Day, B., Jamasb, A. R., Soman, J., Regep, C., Liu, G., Hayter, J. B. R., Vickers, R. J., Roberts, C., Tang, J., et al. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2012.05716 · Cited by 11 · see citing works

A review on cullin neddylation and strategies to identify its inhibitors for cancer therapy

Bano, I., Malhi, M., Zhao, M., Giurgiulescu, L., Sajjad, H., & Kieliszek, M. (2022) · 3 Biotech · doi:10.1007/s13205-022-03162-x · Cited by 10 · see citing works

Identification of a new and diverse set of Mycobacterium tuberculosis uracil-DNA glycosylase (MtUng) inhibitors using structure-based virtual screening: Experimental validation and molecular dynamics studies

Raj, P., Selvam, K., Roy, K., Tripathi, S. M., Kesharwani, S., Gopal, B., Varshney, U., & Sundriyal, S. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.129008 · Cited by 10 · see citing works

Repurposing Selamectin as an Antimicrobial Drug against Hospital-Acquired Staphylococcus aureus Infections

Folliero, V., Dell’Annunziata, F., Santella, B., Roscetto, E., Zannella, C., Capuano, N., Perrella, A., Filippis, A. D., Boccia, G., Catania, M. R., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11092242 · Cited by 10 · see citing works

SpAi: A machine-learning supported experimental workflow for high-throughput spheroid production and analysis

Hacıosmanoğlu, N., Güngen, M. A., Yilmaz, E. G., Ece, E., Uzun, A., Taşcan, A., Görmüş, B. M., Eş, İ., & İnci, F. (2025) · Biosensors and Bioelectronics X · doi:10.1016/j.biosx.2025.100588 · Cited by 9 · see citing works

Ofloxacin as a Disruptor of Actin Aggresome “Hirano Bodies”: A Potential Repurposed Drug for the Treatment of Neurodegenerative Diseases

Pathak, S., Parkar, H., Tripathi, S., & Kale, A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.591579 · Cited by 9 · see citing works

In Silico and In Vitro Potential of FDA-Approved Drugs for Antimalarial Drug Repurposing against Plasmodium Serine Hydroxymethyltransferases

Mee-udorn, P., Phiwkaow, K., Tinikul, R., Sanachai, K., Maenpuen, S., & Rungrotmongkol, T. (2023) · ACS Omega · doi:10.1021/acsomega.3c01309 · Cited by 9 · see citing works

New frontier radioiodinated probe based on in silico resveratrol repositioning for microtubules dynamic targeting

Mahmoud, A. F., Aboumanei, M. H., Abd‐Allah, W. H., Swidan, M. M., & Sakr, T. M. (2022) · International Journal of Radiation Biology · doi:10.1080/09553002.2022.2078001 · Cited by 9 · see citing works

Synthesis and Conformational Analysis of Hydantoin-Based Universal Peptidomimetics

Caramiello, A. M., Bellucci, M. C., Cristina, G., Castellano, C., Meneghetti, F., Mori, M., Secundo, F., Viani, F., Sacchetti, A., & Volonterio, A. (2022) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.2c01903 · Cited by 9 · see citing works

Machine Learning Applications for Drug Repurposing

Yingngam, B. (2024) · doi:10.1002/9781394234196.ch9 · Cited by 9 · see citing works

Drug repurposing: a promising drug discovery strategy for the treatment of emerging epidemic infectious disease

Zhang, S., Zhang, R., Zheng, L., Liu, Y., Fan, Q., Liu, Y., Ning, X., Zhang, Y., Chen, Y., & Liu, H. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11247-x · Cited by 8 · see citing works

Identification of Small Molecular Chaperones Binding P23H Mutant Opsin through an In Silico Structure-Based Approach

Picarazzi, F., Zuanon, M., Pasqualetto, G., Cammarone, S., Romeo, I., Young, M. T., Brancale, A., Bassetto, M., & Mori, M. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01040 · Cited by 8 · see citing works

Unlocking therapeutic potential: integration of drug repurposing and immunotherapy for various disease targeting.

Pawar, V. A., Tyagi, A., Verma, C., Sharma, K. P., Ansari, S., Mani, I., Srivastva, S. K., Shukla, P. K., Kumar, A., & Kumar, V. (2023) · PubMed Central · Cited by 8 · see citing works

Comparative differential cytotoxicity of clinically used SERMs in human cancer lines of different origin and its predictive molecular docking studies of key target genes involved in cancer progression and treatment responses

Lakshmi, S., Shanitha, A., Dv, S., Bs, R., Saikant, R., Sharaf, S., Sa, A., & Rajmohan, G. (2021) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2021.100080 · Cited by 8 · see citing works

Pharmacokinetics and pharmacodynamics analysis of drug candidates

Singh, S., Singh, D. B., Gautam, B., Singh, A., & Yadav, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-89775-4.00001-8 · Cited by 7 · see citing works

Current Status on 1,4-Dihydropyridine Derivatives against Human Pathogenic Parasites

Elso, O. G., Liñares, G. G., & Sülsen, V. P. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867330666221104162901 · Cited by 7 · see citing works

Pathogenesis of COVID19 and the applications of US FDA-approved repurposed antiviral drugs to combat SARS-CoV-2 in Saudi Arabia: A recent update by review of literature

Hershan, A. A. (2024) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2024.104023 · Cited by 7 · see citing works

Development of a High-Throughput Affinity Mass Spectrometry (AMS) Platform Using Laser Diode Thermal Desorption Ionization Coupled to Mass Spectrometry (LDTD-MS)

Sahasrabuddhe, A., Oakley, D., Chen, K., & McCarter, J. D. (2020) · SLAS DISCOVERY · doi:10.1177/2472555220979596 · Cited by 7 · see citing works

Rutin increases alpha‐tubulin acetylation via histone deacetylase 6 inhibition

Çetin, Ö., Sarı, S., Erdem‐Yurter, H., & Bora, G. (2022) · Drug Development Research · doi:10.1002/ddr.21927 · Cited by 8 · see citing works

Dissecting the Mechanism of Action of Spiperone—A Candidate for Drug Repurposing for Colorectal Cancer

Antona, A., Varalda, M., Roy, K., Favero, F., Mazzucco, E., Zuccalà, M., Leo, G., Soggia, G., Bettio, V., Tosi, M., et al. (2022) · Cancers · doi:10.3390/cancers14030776 · Cited by 8 · see citing works

Statins as Antifungal Agents: A Review on Drug Repurposing and Nanotechnology-Driven Delivery Strategies

e Silva, D. M., de Souza Lacerda, L., de Souza Andrioli, A., Braz, W. R., Campos, L. M., de Paiva, M. R. B., Pittella, F., Fabri, R. L., & Tavares, G. D. (2025) · Fundamental &amp; Clinical Pharmacology · doi:10.1111/fcp.70046 · Cited by 7 · see citing works

Anti-aging and immunomodulatory role of caffeine in Drosophila larvae

Nainu, F., Sartini, S., Bahar, M. A., Asbah, A., Rosa, R. A., Mudjahid, M., As’ad, M. F., & Latada, N. P. (2024) · Narra J · doi:10.52225/narra.v4i2.818 · Cited by 6 · see citing works

Antiviral drug development by targeting RNA binding site, oligomerization and nuclear export of influenza nucleoprotein

Panthi, S., Hong, J.-Y., Satange, R., Yu, C., Li, L., & Hou, M. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136996 · Cited by 7 · see citing works

The multitarget approach as a green tool in medicinal chemistry

Vlocskó, R. B., Apaydın, S., Török, B., & Török, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822248-5.00016-4 · Cited by 6 · see citing works

In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library

Orro, A., Uggeri, M., Rusnati, M., Urbinati, C., Pedemonte, N., Pesce, E., Moscatelli, M., Padoan, R., Cichero, E., Fossa, P., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113186 · Cited by 6 · see citing works

Drug repurposing for Alzheimer’s disease using a graph-of-thoughts based large language model to infer drug-disease relationships in a comprehensive knowledge graph

Wang, Z. P., Li, X., Matsumoto, N., Venkatesan, M., Chang, J.-H., Moran, J., Choi, H., Li, B., Meng, Y., Hernandez, M. E., et al. (2025) · BioData Mining · doi:10.1186/s13040-025-00466-5 · Cited by 7 · see citing works

Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias

Moya-Garzón, M. D., Gómez-Vidal, J. A., Alejo‐Armijo, A., Altarejos, J., Madoz, J. R. R., Fernandes, M. X., SALIDO, E. C., Salido, S., & Díaz‐Gavilán, M. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020074 · Cited by 5 · see citing works

CADD Approaches in Anticancer Drug Discovery

Biswas, A., & Jayaprakash, V. (2023) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-99-1316-9_12 · Cited by 5 · see citing works

Computational Modeling to Identify Drugs Targeting Metastatic Castration-Resistant Prostate Cancer Characterized by Heightened Glycolysis

Su, M., Lee, A. M., Zhang, W., Maeser, D., Gruener, R. F., Deng, Y., & Huang, R. S. (2024) · Pharmaceuticals · doi:10.3390/ph17050569 · Cited by 5 · see citing works

Long-range action of an HDAC inhibitor treats chronic pain in a spared nerve injury rat modelPreprint

Centeno, M. V., Alam†, M. S., Haldar, K., & Apkarian, A. V. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.13.571583 · Cited by 5 · see citing works

Advances in the approaches used to repurpose drugs for neuroblastoma

Miera-Maluenda, M., Pérez-Torres, M., Mañas, A., Rubio‐San‐Simón, A., Butjosa-Espín, M., Ruiz-Duran, P., Seoane, J. A., Moreno, L., & Segura, M. F. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2402413 · Cited by 4 · see citing works

A Triple combination formulation of an HDAC inhibitor treats chronic pain in rodent spared nerve injury model

Centeno, M. V., Alam†, M. S., Haldar, K., & Apkarian, A. V. (2025) · Journal of Pain · doi:10.1016/j.jpain.2025.105396 · Cited by 4 · see citing works

Insights into the promising prospect of medicinal chemistry studies against neurodegenerative disorders

Rahman, M. M., Islam, M. R., Tumpa, M. A. A., Shohag, S., shuvo, S. K., Ferdous, J., Kajol, S. A., Aljohani, A. S. M., Abdulmonem, W. A., Rauf, A., et al. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110375 · Cited by 4 · see citing works

A Drug Repurposing Pipeline Based on Bladder Cancer Integrated Proteotranscriptomics Signatures

Mokou, M., Narayanasamy, S., Stroggilos, R., Balaur, I., Vlahou, A., Mischak, H., & Frantzi, M. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3291-8_4 · Cited by 4 · see citing works

Neglected Tropical Diseases: Current Treatment Challenges and Future Therapeutic Potentials

Abdalla, E. H. E., Alenezi, B. T., Soliman, M. M., Jan, M., & Soliman, A. (2025) · Prospects in Pharmaceutical Sciences · doi:10.56782/pps.295 · Cited by 3 · see citing works

Exploring drug repositioning possibilities of kinase inhibitors via molecular simulation**

Wang, Q.-X., Cai, J., Chen, Z., Liu, J., Wang, J., Zhou, H., Li, Q., Wang, Z., Wang, Y., Tong, Z., et al. (2024) · Molecular Informatics · doi:10.1002/minf.202300336 · Cited by 3 · see citing works

Synthesis of New Bi-Triazoles with Plasmocide Action Against Plasmodium falciparum

Addla, D., Diniz, C. S., de Santana, Q. L. O., Martinez, L. D. N., Almeida, M. L., da Silva, M. A., do Nascimento, W. D. S. P., Gouveia, A. D. J., Fialho, S. N., Ferreira, A. D. S., et al. (2022) · Current Bioactive Compounds · doi:10.2174/1573407219666221117113556 · Cited by 3 · see citing works

Recent Advances in the Application of Sulfonic Acid Chitosan as Heterogenous Organocatalyst in Organic Reactions

de Jesus, I. S., de Pontes, J. B., de Carvalho, A. S., Ferreira, P. G., de Souza, A. S., da Silva, F. D. C., Paschoalin, V. M. F., Futuro, D. O., & Ferreira, V. F. (2025) · Current Organic Chemistry · doi:10.2174/0113852728332274241104114316 · Cited by 3 · see citing works

Cytotoxic Activity of Unique Synthesized Five-membered Heterocyclic Compounds Coordinated with Tiopronin Monovalent

Sano, N., Yoshino, H., Sato, Y., HONMA, H., Cordonier, C. E. J., & Kashiwakura, I. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230407094658 · Cited by 3 · see citing works

MIG1, TUP1 and NRG1 mediated yeast to hyphal morphogenesis inhibition in Candida albicans by ganciclovir

Gavandi, T. C., Patil, S. B., Basrani, S. T., Yankanchi, S. R., Chougule, S. A., Karuppayil, S. M., & Jadhav, A. K. (2024) · Brazilian Journal of Microbiology · doi:10.1007/s42770-024-01344-8 · Cited by 2 · see citing works

Harnessing antimalarial chemical space: the way forward

Sundriyal, S., & Majumdar, A. (2025) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2025.2582539 · Cited by 2 · see citing works

Newly Synthesized Telmisartan–Amino Acid Conjugates Exhibit Enhanced Cytotoxic Effects in Malignant Melanoma Cells

Vukadinović, D., Damjanović, A., Vukovic, M., Cudina, O. A., Grahovac, J., & Dobričić, V. (2025) · Molecules · doi:10.3390/molecules31010125 · Cited by 2 · see citing works

Identification of the cannabinoid receptor 1 antagonist, ibipinabant, as a potent inhibitor of Neisseria gonorrhoeae

Dove, A. S., Abdelsattar, A. S., Abutaleb, N. S., & Seleem, M. N. (2026) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01231-25 · Cited by 2 · see citing works

Enhancing Prediction of Drug Indication and Side Effects through Named Entity Recognition and Jointly Learning of Syntactic Structures of Sentences

Mohanapriya, D., & Beena, R. (2020) · European Journal of Molecular & Clinical Medicine · Cited by 2 · see citing works

Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and Rescuing

Fossa, P., Uggeri, M., Orro, A., Urbinati, C., Rondina, A., Milanesi, M., Pedemonte, N., Pesce, E., Padoan, R., Ford, R. C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012274 · Cited by 2 · see citing works

Activate the endogenous Cu2+ switch for Zn(DDC)2 liposomes conversion: Providing a safer and less toxic alternative in cancer therapy

Liang, X., Li, C., Yuan, W., Ji, M., Zhang, J., Yan, M., Lu, Q., Gou, J., Yin, T., He, H., et al. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.123800 · Cited by 2 · see citing works

Drug and formulation development processes

Charoo, N. A., Mohamed, E. M., Eltigani, M., Khan, M. A., Nutan, M. T. H., & Rahman, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91111-5.00007-x · Cited by 2 · see citing works

Computational Approaches for Structure-Assisted Drug Discovery and Repurposing

Pandey, A. K., & Verma, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-7123-3_9 · Cited by 3 · see citing works

Drug Repurposing (DR): An Emerging Approach in Drug Discovery

Rudrapal, M., Khairnar, S. J., & Jadhav, A. G. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.93193 · Cited by 210 · see citing works

Drug Repurposing in Dermatology: Molecular Biology and Omics Approach

Badria, F. A.-E., & Elgazar, A. A. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.93344 · Cited by 3 · see citing works

Drug Repurposing in Modern Pharmacology: A Strategic Review

Imran, D. M. (2025) · HYDERABAD JOURNAL OF SCIENCES

Repurposing Drugs for Skin Cancer

Khachigian, L. M. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867327666191220103901 · Cited by 8 · see citing works

From Lab to Clinic: Success Stories of Repurposed Drugs in Treating Major Diseases

Hussain, M. S., Mir, P. A., Kumar, N., Mohi-ud-din, R., Wali, A. F., Mir, R. H., Talath, S., Sridhar, S. B., Shareef, J., Goud, M., et al. (2025) · Advances in Pharmacological and Pharmaceutical Sciences · doi:10.1155/adpp/1070716 · Cited by 13 · see citing works